Dementias and ageing

Research groups in the Department of Psychiatry are working with hospitals, patients, and industry partners, to translate growing insights into the origins and causes of dementias into effective treatment and prevention.  

We are working to better understand the molecular, cellular and genetic mechanisms of dementia to enable early diagnosis and detection and as well as identifying risk factors to help prevent disease and slow cognitive decline. We are conducting drug trials and using data and machine learning to help find effective treatments. . 

Our teams are also driving forward innovative initiatives to accelerate the pace of research and developing ways to reduce waiting lists and clinic times, which will benefit patients and the NHS, as well as helping reduce the pressure on carers and the economy in the future. 

We host Dementias Platform UK, a partnership between 27 public, industry  and third sector organisations, with core funding from the Medical Research Council. It bring together expertise from universities, charities, and pharmaceutical and technology companies to enable crucial breakthroughs in dementia research.